Division of Cancer Sciences (L5)

Azadeh Abravan
- Division of Cancer Sciences (L5) - Research Associate
Person: Academic
Bilal Alkhaffaf
- bilal.alkhaffafpostgrad.manchester.acuk
- Division of Cancer Sciences (L5) - Honorary Senior Lecturer (Teach & Res)
Person: Academic
Omer Aziz
- Division of Cancer Sciences (L5) - MAHSC Honorary Clinical Chair
Person: Academic
Marianne Aznar
- Division of Cancer Sciences (L5) - Professor of Radiation Oncology Physics
Person: Academic
Jorge Barriuso
- Division of Cancer Sciences (L5) - Clinical Senior Lecturer
Person: Academic

10 - The routine clinical use of electronic patient-reported outcome measures (ePROMs) for patients with lung cancer
Crockett, C., Price, J., Pham, M., Abdulwahid, D., Bayman, N., Blackhall, F., Bostock, L., Califano, R., Chan, C., Coote, J., Cove-Smith, L., Eaton, M., Fenemore, J., Gomes, F., Harris, M., Halkyard, E., Hughes, S., Lindsay, C., Neal, H., McEntee, D., & 7 othersPemberton, L., Sheikh, H., Summers, Y., Taylor, P., Woolf, D., Yorke, J. & Faivre-Finn, C., 24 Apr 2023, (E-pub ahead of print) p. S5-S6. 2 p.
Research output: Contribution to conference › Abstract › peer-review
11MO Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors
Majem, M., Forster, M. D., Krebs, M., Peguero, J., Clay, T., Felip, E., Iams, W., Roxburgh, P., Spéville, B., Bajaj, P., Mueller, C. & Triebel, F., 1 Apr 2023, (E-pub ahead of print) In: Journal of Thoracic Oncology. 18, p. S43-S44
Research output: Contribution to journal › Meeting Abstract › peer-review
124MO A single centre experience of patients with rare cancers referred for early phase clinical trials
Angelakas, A., Cook, N., Graham, D. M., Krebs, M., Thistlethwaite, F. & Carter, L., 22 Mar 2023, In: ESMO Open. 8, 1
Research output: Contribution to journal › Meeting Abstract › peer-review
125 - Implementing a sustainable lung SABR planning pathway: reducing inefficiencies and improving timeliness of treatment
Wooder, R., Banfill, K., Bayman, N., Chan, C., Coote, J., Abdulwahid, D., Faivre-Finn, C., Goldstraw, R., Harris, M., Pemberton, L., Sheikh, H., Whitehurst, P. & Woolf, D., 24 Apr 2023, (E-pub ahead of print) p. S54. 1 p.
Research output: Contribution to conference › Abstract › peer-review
128 - Implementing heart-sparing radiotherapy for lung cancer
Marchant, T., Price, G., McWilliam, A., Van Herk, M., Wood, J., Harris, C., King, J., Banfill, K. & Faivre-Finn, C., 24 Apr 2023, (E-pub ahead of print) p. S55-S56. 2 p.
Research output: Contribution to conference › Abstract › peer-review

3 Finished
5 Active

NIHR Manchester Biomedical Research Centre
Bruce, I., Lord, G., Lennon, R., Black, G., Wedge, D., Morris, A., Hussell, T., Sharrocks, A., Stivaros, S., Buch, M., Gough, J., Kostarelos, K., Thistlethwaite, F., Kadler, K., Barton, A., Hyrich, K., Mcbeth, J., O'Neill, T., Vestbo, J., Simpson, A., Singh, S., Smith, J., Felton, T., Murray, C., Griffiths, C., Cullum, N., Rhodes, L., Warren, R., Paus, R., Dumville, J., Viros Usandizaga, A., Keavney, B., Tomaszewski, M., Allan, S., Body, R., Cartwright, E., Heagerty, A., Kalra, P., Miller, C., Rutter, M., Smith, C., Trafford, A., Evans, D., Crosbie, E., Crosbie, P., Harvie, M., Howell, S., Renehan, A., Dive, C., Blackhall, F., Landers, D., Krebs, M., Cook, N., Clarke, R., Taylor, S., Jorgensen, C., Lorigan, P., Jayson, G., Valle, J., Mccabe, M., Armstrong, A., Freitas, A., Illidge, T., Choudhury, A., Hoskin, P., West, C., Van Herk, M., Faivre-Finn, C., Bristow, R., Kirkby, K., Birtle, A., Mackay, R., Radford, J., Linton, K., Higham, C., Munro, K., Plack, C., Arden Armitage, C., Bruce, I., Moore, D., Saunders, G., Stone, M., Haddock, G., Lewis, S., Elliott, R., Green, J., Lovell, K., Morrison, A., Shaw, J., Bucci, S., Ainsworth, J., Webb, R., Newman, W., Banka, S., Clayton-Smith, J., Payne, K., Moldovan, R., Wynn, R. & Jones, S.
1/12/22 → 30/11/27
Project: Research
3D-printed silicone soft-robotic “4D” phantoms for developing MR-guided radiotherapy
Derby, B., Dickie, B., Edmondson, S., O'Connor, J. & Wang, C. C. L.
1/03/22 → 28/02/25
Project: Research
RAPID-RT: Using real world data and rapid learning to drive improvements in lung cancer survival
Faivre-Finn, C., Devaney, S., French, D., Holm, S., Kontopantelis, E., Mcwilliam, A., Payne, K., Price, G., Proudlove, N., Sanders, C. & Van Staa, T.
1/11/21 → 31/10/26
Project: Research
Turing AI Fellowship: Human-AI Research Teams - Steering AI in Experimental Design and Decision-Making
Kaski, S., Bristow, R., Cai, P., Jay, C. & Peek, N.
1/10/21 → 30/09/26
Project: Research
PKC/TGF- SIGNALLING AXIS: A NOVEL THERAPEUTIC TARGET FOR ARTERIAL MEDIAL CALCIFICATION
Borland, S., Canfield, A., Brennan, K., Ashton, N. & Sherratt, M.
1/02/21 → 31/01/24
Project: Research

Access to more effective therapies in Non-Hodgkin Lymphoma
Timothy Illidge (Corresponding participant), John Radford (Participant) & Jamie Honeychurch (Participant)
Impact: Health and wellbeing, Economic
Adjuvant therapy in melanoma adopted as standard of care
Paul Lorigan (Participant)
Impact: Health and wellbeing
A phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine (GemX) in muscle-invasive bladder cancer.
Ananya Choudhury (Participant)
Impact: Health impacts
A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation
Peter Hoskin (Participant), Angela R. McLean (Participant), Ella K Adlen (Participant), Elisabeth Cardis (Participant), Dudley T Goodhead (Participant), Mats Harms-Ringdahl (Participant), JH. Hendry (Participant), Penny A. Jeggo (Participant), DJC Mackay (Participant), Colin R Muirhead (Participant), J Shepherd (Participant), R. E. Shore (Participant), GA Thomas (Participant), R Wakeford (Participant) & H. Charles J Godfray (Participant)
Impact: Health impacts
Chair of ESMO GU oncology guidelines
Silke Gillessen Sommer (Participant)
Impact

Osteoporosis International (Journal)
Tanuj Puri (Assistant editor)
Oct 2023
Activity: Publication peer-review and editorial work › Publication peer-review › Research
Frontiers in Nuclear Medicine (Journal)
Tanuj Puri (Assistant editor)
Oct 2023
Activity: Publication peer-review and editorial work › Editorial work › Research
MDPI AG (External organisation)
Tanuj Puri (Academic expert member)
26 Sept 2023
Activity: Membership › Membership of committee › Research
AAPM's Diversity and Inclusion Subcommittee (DISC) (External organisation)
Tanuj Puri (Academic expert member)
5 Sept 2023 → …
Activity: Membership › Membership of committee › Research
EJNMMI Physics (Journal)
Tanuj Puri (Assistant editor)
Aug 2023 → …
Activity: Publication peer-review and editorial work › Publication peer-review › Research

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)
Wade, J. (Contributor), Elliott, D. (Contributor), Avery, K. N. L. (Contributor), Gaunt, D. (Contributor), Young, G. J. (Contributor), Barnes, R. (Contributor), Paramasivan, S. (Contributor), Campbell, W. B. (Contributor), Blazeby, J. M. (Contributor), Birtle, A. (Contributor), Stein, R. C. (Contributor), Beard, D. J. (Contributor), Halliday, A. W. (Contributor) & Donovan, J. L. (Contributor), figshare , 17 Jul 2017
DOI: 10.6084/m9.figshare.c.3829015.v1, https://figshare.com/collections/Informed_consent_in_randomised_controlled_trials_development_and_preliminary_evaluation_of_a_measure_of_Participatory_and_Informed_Consent_PIC_/3829015/1
Dataset
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
Valpione, S. (Creator), Pasquali, S. (Creator), Campana, L. G. (Creator), Piccin, L. (Creator), Mocellin, S. (Creator), Pigozzo, J. (Creator) & Chiarion-Sileni, V. (Creator), figshare , 11 Apr 2018
DOI: 10.6084/m9.figshare.c.4067036
Dataset
Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial
Howard, D. R. (Contributor), Munir, T. (Contributor), Hockaday, A. (Contributor), Rawstron, A. C. (Contributor), Collett, L. (Contributor), Oughton, J. B. (Contributor), Allsup, D. (Contributor), Bloor, A. (Contributor), Phillips, D. (Contributor) & Hillmen, P. (Contributor), figshare , 20 Sept 2016
DOI: 10.6084/m9.figshare.c.3627080.v1, https://figshare.com/collections/Chemotherapy_plus_Ofatumumab_at_Standard_or_Mega_dose_in_relapsed_CLL_COSMIC_trial_study_protocol_for_a_phase_II_randomised_controlled_trial/3627080/1
Dataset
DNA methylation of the <i>Oct4A</i> enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells
Baryshev, M. (Creator), Inashkina, I. (Creator), Salmina, K. (Creator), Huna, A. (Creator), Jackson, T. (Creator) & Erenpreisa, J. (Creator), figshare , 31 Mar 2018
DOI: 10.6084/m9.figshare.6000263
Dataset
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial
Collett, L. (Contributor), Howard, D. R. (Contributor), Munir, T. (Contributor), McParland, L. (Contributor), Oughton, J. B. (Contributor), Rawstron, A. C. (Contributor), Hockaday, A. (Contributor), Dimbleby, C. (Contributor), Phillips, D. (Contributor), McMahon, K. (Contributor), Hulme, C. (Contributor), Allsup, D. (Contributor), Bloor, A. (Contributor) & Hillmen, P. (Contributor), figshare , 1 Jan 2017
DOI: 10.6084/m9.figshare.c.3860632.v1, https://figshare.com/collections/Assessment_of_ibrutinib_plus_rituximab_in_front-line_CLL_FLAIR_trial_study_protocol_for_a_phase_III_randomised_controlled_trial/3860632/1
Dataset

1st Annual Brady Award for Resident Research, Joint Oncology Program. University of Toronto, Toronto, Ontario
Bristow, Robert (Recipient), 1996
Prize: Prize (including medals and awards)
1st place Student Poster Prize
Shafiee PhD.Sc, Sahba (Recipient), 20 May 2014
Prize: Other distinction
2018 Outstanding Clinical Contribution to The Christie NHS Foundation Trust
Hughes, Andrew (Recipient), May 2018
Prize: Prize (including medals and awards)
2-year KWF (Dutch Cancer Soceity) fellowship (laboratory of Prof. Robert Bristow, Princess Margaret Cancer Centre, Toronto, Canada)
Borst, Gerben (Recipient), 2012
Prize: Prize (including medals and awards)
AACR Women in Cancer Research Scholar Award
Conway, Alicia-Marie (Recipient), 2022
Prize: Prize (including medals and awards)

Patients with rare cancers given hope by UK-led ‘drug-match’ trial 'DETERMINE'
Matthew Krebs
14/10/23 → 15/10/23
2 items of Media coverage
Press/Media: Research
Data science in healthcare - Estimating bone remodelling using PET imaging
Tanuj Puri
8/10/23
1 Media contribution
Press/Media: Other
AI study aims to improve radiotherapy for lung cancer patients and prevent patients getting heart disease
Corinne Faivre-Finn
10/09/23 → 12/09/23
3 items of Media coverage
Press/Media: Research
Phase I trial of divarasib show positive results for patients with Kras-mutated solid tumours
Matthew Krebs
24/08/23 → 5/09/23
3 items of Media coverage
Press/Media: Research
A 4-min PET scan to estimate bone formation rate (Ki).
Tanuj Puri
29/06/23
1 Media contribution
Press/Media: Other

Investigation of Preventive Tamoxifen Resistance Mechanisms in the Normal Breast
Author: Alghamdi, S., 2022
Supervisor: Howell, S. (Supervisor), Clarke, R. (Supervisor) & Simões, B. M. (Supervisor)
Student thesis: Doctoral Thesis
PREDICTION AND VALIDATION OF NOVEL DRUG SYNERGY
Author: Criscuolo, C., 2022
Supervisor: Simões, B. M. (Supervisor) & Townsend, P. (Supervisor)
Student thesis: Doctoral Thesis

Division of Cancer Sciences (L5)

Organisation profile

Overview

Collaborations and top research areas from the last five years

Profiles

Research output

Projects

Impacts

Activities

Datasets

Prizes

Press/Media

Student theses